ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000225039.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.018605903	Resistant
ENSG00000225039.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.017932026	Resistant